Mary Jane Hogan
MD, MPH, FAAP
Associate Professor of Pediatrics (Hematology/Oncology)
Research & Publications
Biography
News
Coauthors
Selected Publications
- Persistent Hypoxemia in an Asymptomatic 4-year-old Boy.Brumer E, de Ángel Solá D, Hogan M, Chen L. Persistent Hypoxemia in an Asymptomatic 4-year-old Boy. Pediatrics In Review 2023, 44: 290-293. PMID: 37122046, DOI: 10.1542/pir.2021-005293.
- Increased Leukemia Risk in Children With Down SyndromeHogan M. Increased Leukemia Risk in Children With Down Syndrome. AAP Grand Rounds 2021, 46: 45-45. DOI: 10.1542/gr.46-4-45.
- Symptoms in Infants and Toddlers With von Willebrand DiseaseHogan M. Symptoms in Infants and Toddlers With von Willebrand Disease. AAP Grand Rounds 2021, 46: 31-31. DOI: 10.1542/gr.46-3-31.
- Hydroxyurea Prescribing Impact in Sickle Cell AnemiaHogan M. Hydroxyurea Prescribing Impact in Sickle Cell Anemia. AAP Grand Rounds 2021, 46: 11-11. DOI: 10.1542/gr.46-1-11.
- The ASH‐ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to questionO'Brien SH, Badawy SM, Rotz SJ, Shah MD, Makarski J, Bercovitz RS, Hogan M, Luchtman‐Jones L, Panepinto JA, Priola GM, Witmer CM, Wolfson JA, Yee M, Hicks LK. The ASH‐ASPHO Choosing Wisely Campaign: 5 hematologic tests and treatments to question. Pediatric Blood & Cancer 2021, 68: e28967. PMID: 34047047, DOI: 10.1002/pbc.28967.
- Dietary Advice Improves Non-Anemic Iron DeficiencyHogan M. Dietary Advice Improves Non-Anemic Iron Deficiency. AAP Grand Rounds 2021, 45: 57-57. DOI: 10.1542/gr.45-5-57.
- Hemoglobin Transfusion Thresholds Outcomes for Preterm InfantsHogan M. Hemoglobin Transfusion Thresholds Outcomes for Preterm Infants. AAP Grand Rounds 2021, 45: 42-42. DOI: 10.1542/gr.45-4-42.
- Outcomes After Splenectomy for Congenital Hemolytic AnemiaHogan M. Outcomes After Splenectomy for Congenital Hemolytic Anemia. AAP Grand Rounds 2021, 45: 21-21. DOI: 10.1542/gr.45-2-21.
- HPV Vaccine Reduces Risk of Invasive Cervical CancerHogan M. HPV Vaccine Reduces Risk of Invasive Cervical Cancer. AAP Grand Rounds 2021, 45: 11-11. DOI: 10.1542/gr.45-1-11.
- Isolated Neutropenia and Clinical OutcomesHogan M. Isolated Neutropenia and Clinical Outcomes. AAP Grand Rounds 2020, 44: 71-71. DOI: 10.1542/gr.44-6-71.
- Maternal HLA Type and Fetal/Neonatal Alloimmune ThrombocytopeniaHogan M. Maternal HLA Type and Fetal/Neonatal Alloimmune Thrombocytopenia. AAP Grand Rounds 2020, 44: 55-55. DOI: 10.1542/gr.44-5-55.
- Early Factor VIII Prophylaxis Prevents Joint Damage in HemophiliaHogan M. Early Factor VIII Prophylaxis Prevents Joint Damage in Hemophilia. AAP Grand Rounds 2020, 44: 44-44. DOI: 10.1542/gr.44-4-44.
- Warmed Saline for Vaso-oclusive Episodes in Sickle Cell DiseaseHogan M. Warmed Saline for Vaso-oclusive Episodes in Sickle Cell Disease. AAP Grand Rounds 2020, 44: 35-35. DOI: 10.1542/gr.44-3-35.
- Transplantation Outcomes in Diamond-Blackfan AnemiaHogan M. Transplantation Outcomes in Diamond-Blackfan Anemia. AAP Grand Rounds 2020, 44: 22-22. DOI: 10.1542/gr.44-2-22.
- Adverse Events With Central Venous CathetersHogan M. Adverse Events With Central Venous Catheters. AAP Grand Rounds 2020, 43: 56-56. DOI: 10.1542/gr.43-5-56.
- Risk of Second Malignancy in Survivors of Childhood CancerHogan M. Risk of Second Malignancy in Survivors of Childhood Cancer. AAP Grand Rounds 2020, 43: 46-46. DOI: 10.1542/gr.43-4-46.
- Late Infections in Survivors of Childhood LeukemiaHogan M. Late Infections in Survivors of Childhood Leukemia. AAP Grand Rounds 2020, 43: 21-21. DOI: 10.1542/gr.43-2-21.
- Head and Neck Melanoma in Children and Young AdultsHogan M. Head and Neck Melanoma in Children and Young Adults. AAP Grand Rounds 2020, 43: 3-3. DOI: 10.1542/gr.43-1-3.
- Laboratory Values in Iron Deficiency Anemia and β-Thalassemia TraitHogan M. Laboratory Values in Iron Deficiency Anemia and β-Thalassemia Trait. AAP Grand Rounds 2019, 42: 46-46. DOI: 10.1542/gr.42-4-46.
- Hemoglobin S Polymerization Inhibitor in Sickle Cell DiseaseHogan M. Hemoglobin S Polymerization Inhibitor in Sickle Cell Disease. AAP Grand Rounds 2019, 42: 30-30. DOI: 10.1542/gr.42-3-30.
- Lentiviral Vector Gene Therapy for X-linked SCIDHogan M. Lentiviral Vector Gene Therapy for X-linked SCID. AAP Grand Rounds 2019, 42: 8-8. DOI: 10.1542/gr.42-1-8.
- Hydroxyurea Treatment for Sickle Cell Anemia in AfricaHogan M. Hydroxyurea Treatment for Sickle Cell Anemia in Africa. AAP Grand Rounds 2019, 41: 53-53. DOI: 10.1542/gr.41-5-53.
- Health Outcomes and Sickle Cell TraitHogan M. Health Outcomes and Sickle Cell Trait. AAP Grand Rounds 2019, 41: 33-33. DOI: 10.1542/gr.41-3-33.
- Platelet Transfusion Trial in Neonatal ThrombocytopeniaHogan M. Platelet Transfusion Trial in Neonatal Thrombocytopenia. AAP Grand Rounds 2019, 41: 19-19. DOI: 10.1542/gr.41-2-19.
- Bacteremia in Febrile Children With Sickle Cell AnemiaHogan M. Bacteremia in Febrile Children With Sickle Cell Anemia. AAP Grand Rounds 2019, 41: 9-9. DOI: 10.1542/gr.41-1-9.
- Intravenous Immunoglobulin in Acute Immune ThrombocytopeniaHogan M. Intravenous Immunoglobulin in Acute Immune Thrombocytopenia. AAP Grand Rounds 2018, 40: 65-65. DOI: 10.1542/gr.40-6-65.
- Late Mortality After Pediatric Autologous Blood or Marrow TransplantHogan M. Late Mortality After Pediatric Autologous Blood or Marrow Transplant. AAP Grand Rounds 2018, 40: 57-57. DOI: 10.1542/gr.40-5-57.
- Improved Outcomes With L-Glutamine Use in Sickle Cell DiseaseHogan M. Improved Outcomes With L-Glutamine Use in Sickle Cell Disease. AAP Grand Rounds 2018, 40: 40-40. DOI: 10.1542/gr.40-4-40.
- Isolated Mild to Moderate Thrombocytopenia in ChildrenHogan M. Isolated Mild to Moderate Thrombocytopenia in Children. AAP Grand Rounds 2018, 40: 30-34. DOI: 10.1542/gr.40-3-30.
- Clinical Spectrum of Pyruvate Kinase DeficiencyHogan M. Clinical Spectrum of Pyruvate Kinase Deficiency. AAP Grand Rounds 2018, 40: 22-22. DOI: 10.1542/gr.40-2-22.
- Parental perception of child vulnerability in childhood cancer survivorsHogan M, Ross WL, Balsamo L, Mitchell H, Kadan‐Lottick N. Parental perception of child vulnerability in childhood cancer survivors. Pediatric Blood & Cancer 2018, 65: e27364. PMID: 30024087, DOI: 10.1002/pbc.27364.
- Risk Factors for Development of Acute Chest SyndromeHogan M. Risk Factors for Development of Acute Chest Syndrome. AAP Grand Rounds 2018, 39: 59-59. DOI: 10.1542/gr.39-5-59.
- Childhood Cancer Survivors at Risk for Brain TumorsHogan M. Childhood Cancer Survivors at Risk for Brain Tumors. AAP Grand Rounds 2018, 39: 33-33. DOI: 10.1542/gr.39-3-33.
- Bruising Patterns in Young Children With Bleeding DisordersHogan M. Bruising Patterns in Young Children With Bleeding Disorders. AAP Grand Rounds 2018, 39: 29-29. DOI: 10.1542/gr.39-3-29.
- Resolution Predictors of Childhood Immune ThrombocytopeniaHogan M. Resolution Predictors of Childhood Immune Thrombocytopenia. AAP Grand Rounds 2017, 38: 52-52. DOI: 10.1542/gr.38-5-52.
- Emicizumab Reduces Bleeding in Hemophilia A With InhibitorsHogan M. Emicizumab Reduces Bleeding in Hemophilia A With Inhibitors. AAP Grand Rounds 2017, 38: 44-44. DOI: 10.1542/gr.38-4-44.
- Higher Birth Weight Linked to Osteosarcoma SeverityHogan M. Higher Birth Weight Linked to Osteosarcoma Severity. AAP Grand Rounds 2017, 38: 35-35. DOI: 10.1542/gr.38-3-35.
- Risk Factors for Early Death in Childhood CancerHogan M. Risk Factors for Early Death in Childhood Cancer. AAP Grand Rounds 2017, 38: 23-23. DOI: 10.1542/gr.38-2-23.
- Congenital Cytomegalovirus Infection and Acute Lymphoblastic LeukemiaHogan M. Congenital Cytomegalovirus Infection and Acute Lymphoblastic Leukemia. AAP Grand Rounds 2017, 37: 70-70. DOI: 10.1542/gr.37-6-70.
- Cancer Risk After Growth Hormone TherapyHogan M. Cancer Risk After Growth Hormone Therapy. AAP Grand Rounds 2017, 37: 71-71. DOI: 10.1542/gr.37-6-71.
- Management of Fetal/Neonatal Alloimmune ThrombocytopeniaHogan M. Management of Fetal/Neonatal Alloimmune Thrombocytopenia. AAP Grand Rounds 2017, 37: 57-57. DOI: 10.1542/gr.37-5-57.
- Intravenous Ferric Carboxymaltose for Iron Deficiency AnemiaHogan M. Intravenous Ferric Carboxymaltose for Iron Deficiency Anemia. AAP Grand Rounds 2017, 37: 22-22. DOI: 10.1542/gr.37-2-22.
- Clinical Presentation of LeukemiaHogan M. Clinical Presentation of Leukemia. AAP Grand Rounds 2016, 36: 70-70. DOI: 10.1542/gr.36-6-70.
- Endocrinopathies in Childhood Cancer SurvivorsHogan M. Endocrinopathies in Childhood Cancer Survivors. AAP Grand Rounds 2016, 36: 41-41. DOI: 10.1542/gr.36-4-41.
- Romiplostim Therapy of Immune ThrombocytopeniaHogan M. Romiplostim Therapy of Immune Thrombocytopenia. AAP Grand Rounds 2016, 36: 34-34. DOI: 10.1542/gr.36-3-34.
- Hearing Loss After Cranial Irradiation for Childhood CancerHogan M. Hearing Loss After Cranial Irradiation for Childhood Cancer. AAP Grand Rounds 2016, 36: 32-32. DOI: 10.1542/gr.36-3-32.
- Cardiovascular Disease Risk After Adolescent & Young Adult CancerHogan M. Cardiovascular Disease Risk After Adolescent & Young Adult Cancer. AAP Grand Rounds 2016, 36: 6-6. DOI: 10.1542/gr.36-1-6.
- Navigating your career path in pediatric hematology/oncology: On and off the beaten trackZweidler-McKay PA, Hogan MJ, Jubran R, Black V, Casillas J, Harper J, Malempati S, Margolin J, Felgenhauer J, Sakamoto KM, Franklin J, Shah M, Seibel N, Buchanan G, Vaiselbuh SR, Hastings C, Hilden J, Stork LC. Navigating your career path in pediatric hematology/oncology: On and off the beaten track. Pediatric Blood & Cancer 2016, 63: 1723-1730. PMID: 27295503, DOI: 10.1002/pbc.26094.
- Late Mortality After Childhood CancerHogan M. Late Mortality After Childhood Cancer. AAP Grand Rounds 2016, 35: 56-56. DOI: 10.1542/gr.35-5-56.
- Heritable Mutations in Pediatric CancerHogan M. Heritable Mutations in Pediatric Cancer. AAP Grand Rounds 2016, 35: 43-43. DOI: 10.1542/gr.35-4-43.
- Pediatric Outcomes After Maternal Cancer During PregnancyHogan M. Pediatric Outcomes After Maternal Cancer During Pregnancy. AAP Grand Rounds 2016, 35: 19-19. DOI: 10.1542/gr.35-2-19.
- Pesticides and Childhood CancerHogan M. Pesticides and Childhood Cancer. AAP Grand Rounds 2015, 34: 66-66. DOI: 10.1542/gr.34-6-66.
- Neurocognitive Deficits After ChemotherapyHogan M. Neurocognitive Deficits After Chemotherapy. AAP Grand Rounds 2015, 34: 53-53. DOI: 10.1542/gr.34-5-53.
- Symptom Distress in Children With Advanced CancerHogan M. Symptom Distress in Children With Advanced Cancer. AAP Grand Rounds 2015, 34: 42-42. DOI: 10.1542/gr.34-4-42.
- Pulmonary Function in Childhood Cancer SurvivorsHogan M. Pulmonary Function in Childhood Cancer Survivors. AAP Grand Rounds 2015, 34: 31-31. DOI: 10.1542/gr.34-3-31.
- Hemoglobinopathy Screening in a 15-Year-old Patient With AnemiaHonarpisheh H, Hogan M, Rinder HM, Siddon AJ. Hemoglobinopathy Screening in a 15-Year-old Patient With Anemia. Journal Of Pediatric Hematology/Oncology 2015, 37: 472-473. PMID: 26181419, DOI: 10.1097/mph.0000000000000357.
- Prevalence and Burden of Morbidity in Childhood Cancer SurvivorsHogan M. Prevalence and Burden of Morbidity in Childhood Cancer Survivors. AAP Grand Rounds 2015, 34: 21-21. DOI: 10.1542/gr.34-2-21.
- Screening for Steroid-Induced Hip Osteonecrosis in LeukemiaHogan M. Screening for Steroid-Induced Hip Osteonecrosis in Leukemia. AAP Grand Rounds 2015, 33: 66-66. DOI: 10.1542/gr.33-6-66.
- Sun Protection Among Children of Melanoma SurvivorsHogan M. Sun Protection Among Children of Melanoma Survivors. AAP Grand Rounds 2015, 33: 67-67. DOI: 10.1542/gr.33-6-67.
- Emergency Department Visits for Children With CancerHogan M. Emergency Department Visits for Children With Cancer. AAP Grand Rounds 2015, 33: 56-56. DOI: 10.1542/gr.33-5-56.
- Cognitive Function After Hematopoietic Stem Cell TransplantationHogan M. Cognitive Function After Hematopoietic Stem Cell Transplantation. AAP Grand Rounds 2015, 33: 34-34. DOI: 10.1542/gr.33-3-34.
- Burden of Central Line Infections in Hematology-Oncology PatientsHogan M. Burden of Central Line Infections in Hematology-Oncology Patients. AAP Grand Rounds 2015, 33: 27-27. DOI: 10.1542/gr.33-3-27.
- Obesity Affects Outcomes in Pediatric LeukemiaHogan M. Obesity Affects Outcomes in Pediatric Leukemia. AAP Grand Rounds 2015, 33: 18-18. DOI: 10.1542/gr.33-2-18.
- Late Infections in Childhood Cancer SurvivorsHogan M. Late Infections in Childhood Cancer Survivors. AAP Grand Rounds 2015, 33: 5-5. DOI: 10.1542/gr.33-1-5.
- Posttraumatic Stress in Pediatric Cancer PatientsHogan M. Posttraumatic Stress in Pediatric Cancer Patients. AAP Grand Rounds 2015, 33: 6-6. DOI: 10.1542/gr.33-1-6.
- Oral Chemotherapy Adherence in Children With LeukemiaHogan M. Oral Chemotherapy Adherence in Children With Leukemia. AAP Grand Rounds 2015, 33: 3-3. DOI: 10.1542/gr.33-1-3.
- New health conditions identified at a regional childhood cancer survivor clinic visitHogan M, Ma X, Kadan‐Lottick N. New health conditions identified at a regional childhood cancer survivor clinic visit. Pediatric Blood & Cancer 2012, 60: 682-687. PMID: 23023769, DOI: 10.1002/pbc.24360.
- Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models.Staba MJ, Wickham TJ, Kovesdi I, Hallahan DE. Modifications of the fiber in adenovirus vectors increase tropism for malignant glioma models. Cancer Gene Therapy 2000, 7: 13-9. PMID: 10678351, DOI: 10.1038/sj.cgt.7700104.
- Enhanced eradication of local and distant tumors by genetically produced interleukin-12 and radiation.Seetharam S, Staba MJ, Schumm LP, Schreiber K, Schreiber H, Kufe DW, Weichselbaum RR. Enhanced eradication of local and distant tumors by genetically produced interleukin-12 and radiation. International Journal Of Oncology 1999, 15: 769-73. PMID: 10493960.
- Radiation-inducible gene therapy.Mauceri HJ, Hanna NN, Staba MJ, Beckett MA, Kufe DW, Weichselbaum RR. Radiation-inducible gene therapy. Comptes Rendus De L'Académie Des Sciences. Série III, Sciences De La Vie 1999, 322: 225-8. PMID: 10196676.
- X-ray-induced P-selectin localization to the lumen of tumor blood vessels.Hallahan DE, Staba-Hogan MJ, Virudachalam S, Kolchinsky A. X-ray-induced P-selectin localization to the lumen of tumor blood vessels. Cancer Research 1998, 58: 5216-20. PMID: 9823335.
- Combined effects of angiostatin and ionizing radiation in antitumour therapy.Mauceri HJ, Hanna NN, Beckett MA, Gorski DH, Staba MJ, Stellato KA, Bigelow K, Heimann R, Gately S, Dhanabal M, Soff GA, Sukhatme VP, Kufe DW, Weichselbaum RR. Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature 1998, 394: 287-91. PMID: 9685160, DOI: 10.1038/28412.
- Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft.Staba MJ, Mauceri HJ, Kufe DW, Hallahan DE, Weichselbaum RR. Adenoviral TNF-alpha gene therapy and radiation damage tumor vasculature in a human malignant glioma xenograft. Gene Therapy 1998, 5: 293-300. PMID: 9614548, DOI: 10.1038/sj.gt.3300594.
- Allogeneic bone marrow transplantation for Alexander's disease.Staba MJ, Goldman S, Johnson FL, Huttenlocher PR. Allogeneic bone marrow transplantation for Alexander's disease. Bone Marrow Transplantation 1997, 20: 247-9. PMID: 9257894, DOI: 10.1038/sj.bmt.1700871.
- AMA Complete Guide to Your Children’s Health.Editor Traisman ES, Asst. Editors Staba MJ, Judy KR. Random House, New York, 1999.